Answer questions and earn CME/CNE Pancreatic cancer is currently one of the deadliest of
the solid malignancies. However, surgery to resect neoplasms of the pancreas is safer and …

PURPOSE The effects of preoperative versus postoperative fluorouracil (5-FU)-based
chemotherapy and irradiation on treatment toxicity, duration of treatment, tumor recurrence …

Background The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is
poor and selection of patients for surgery is challenging. This study examined the impact of a …

Background The effect of adjuvant treatment on survival in pancreatic cancer is unclear. We
report the final results of the European Study Group for Pancreatic Cancer 1 Trial and …

This large-volume, single-institution review examines factors influencing long-term survival
after resection in patients with adenocarcinoma of the head, neck, uncinate process, body …

Objective: Patients who undergo an R0 resection of their pancreatic ductal adenocarcinoma
(PDAC) have an improved survival compared with patients who undergo an R1 resection. It …

Background The role of adjuvant treatment in pancreatic cancer remains uncertain. The
European Study Group for Pancreatic Cancer (ESPAC) assessed the roles of …

Background Curative resection has been shown to be one of the key factors influencing
survival of pancreatic ductal adenocarcinoma (PDAC) patients. Although general guidelines …

Objective: This single-institution study examined the outcome after
pancreaticoduodenectomy in patients with adenocarcinoma of the head of the pancreas …

Background Resection margin (RM) status in pancreatic head adenocarcinoma is assessed
histologically, but pathological examination is not standardized. The aim of this study was to …